B cell-activating factor and its targeted therapy in autoimmune diseases

Area of Science:

• Immunology
• Autoimmunity
• Cell Biology

Background:

• B cells are central to autoimmune disease (AD) pathogenesis through autoantibody production, cytokine secretion, and autoantigen presentation.
• B cell-activating factor (BAFF), a pro-survival factor, is crucial for B cell maturation and homeostasis.
• Elevated BAFF levels are observed in AD patients and models, correlating with autoantibody production.

Purpose of the Study:

• To review recent findings on BAFF expression and its mechanisms in autoimmune pathogenesis.
• To discuss newly developed therapeutic strategies targeting BAFF for AD treatment.

Main Methods:

• Literature review of studies on BAFF in autoimmune diseases.
• Analysis of BAFF's role in B cell survival and autoreactivity.
• Examination of clinical data on BAFF-targeted therapies.

Main Results:

• BAFF promotes the survival and expansion of autoreactive B cells that escape apoptosis.
• Increased BAFF levels are a hallmark of various autoimmune conditions.
• BAFF is implicated in driving autoimmune progression and autoantibody production.

Conclusions:

• BAFF plays a critical role in the pathogenesis of autoimmune diseases.
• Targeting BAFF represents a viable therapeutic approach for managing autoimmune conditions.
• Further research into BAFF effector mechanisms and targeted therapies is warranted.